An expert summary of the diagnostic and prognostic value of biomarkers related to alterations in the most common types of lymphoma at the genetic, epigenetic, protein, and tumor microenvironment levels.
Mod Pathol 2016; 29: 1118–1142. doi:10.1038/modpathol.2016.92
This article reviews the computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) CT findings of primary and secondary pancreatic lymphomas and discusses the role of endoscopic ultrasound-guided fine needle aspiration in diagnosis and management.
Anand D et al. Abdom Radiol 2016; 41: 347–355. doi:10.1007/s00261-015-0620-8
Howell et al determine that hematological malignancies have varying presentations by subtype but there is a worrying lack of public awareness of the differing clinical presentations, which is causing delayed diagnosis.
Br J Cancer 2015; 113: 1114–1120. doi:10.1038/bjc.2015.311
This review evaluates the use of imaging in patients with non-Hodgkin lymphoma before, during, and after therapy with an insight into future developments in the field including new positron emission tomography tracers.
El-Galaly TC & Hutchings M. In: Non-Hodgkin Lymphoma. Edited by Evens AM & Blum KA. Springer International Publishing, 2015. doi:10.1007/978-3-319-13150-4_5